Artificial liver assist devices offer a temporary solution for liver failure. Plasma exchange therapy showed a significant survival benefit in fulminant hepatic failure patients, but challenges remain for future development.
Area of Science:
You might also read
Articles linked to this work by shared authors, journal, and citation graph.